CAI financials
Caris Life Sciences (CAI) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
CAI income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $812.03M | $539.17M | $45.11M | -$537.96M | -1.86 |
| 2024 | $412.26M | $178.78M | -$257.12M | -$281.89M | -2.70 |
| 2023 | $306.13M | $89.31M | -$319.55M | -$341.42M | -1.82 |
| 2022 | $258.49M | $80.02M | -$315.76M | -$320.83M | -1.57 |
| 2020 | $294.01M | $184.16M | $139.09M | $27.73M | 1.55 |
| 2019 | $416.54M | $200.51M | $130.28M | $31.01M | 1.72 |
- CAI revenue was $812.03M in fiscal 2025, net income -$537.96M.
Updated 2026-11-02 23:14 UTC